rs10780691

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000304053.11(NTRK2):​c.*4521C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.482 in 1,049,362 control chromosomes in the GnomAD database, including 126,204 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 13186 hom., cov: 32)
Exomes 𝑓: 0.50 ( 113018 hom. )

Consequence

NTRK2
ENST00000304053.11 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.602

Publications

16 publications found
Variant links:
Genes affected
NTRK2 (HGNC:8032): (neurotrophic receptor tyrosine kinase 2) This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation. Mutations in this gene have been associated with obesity and mood disorders. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
NTRK2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 58
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • obesity, hyperphagia, and developmental delay
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.501 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NTRK2NM_006180.6 linkc.1633+8907C>T intron_variant Intron 14 of 18 ENST00000277120.8 NP_006171.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NTRK2ENST00000277120.8 linkc.1633+8907C>T intron_variant Intron 14 of 18 1 NM_006180.6 ENSP00000277120.3

Frequencies

GnomAD3 genomes
AF:
0.392
AC:
59580
AN:
151910
Hom.:
13183
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.181
Gnomad AMI
AF:
0.431
Gnomad AMR
AF:
0.407
Gnomad ASJ
AF:
0.456
Gnomad EAS
AF:
0.263
Gnomad SAS
AF:
0.517
Gnomad FIN
AF:
0.445
Gnomad MID
AF:
0.402
Gnomad NFE
AF:
0.506
Gnomad OTH
AF:
0.409
GnomAD4 exome
AF:
0.497
AC:
446146
AN:
897334
Hom.:
113018
Cov.:
29
AF XY:
0.498
AC XY:
206380
AN XY:
414474
show subpopulations
African (AFR)
AF:
0.161
AC:
3037
AN:
18840
American (AMR)
AF:
0.429
AC:
1255
AN:
2928
Ashkenazi Jewish (ASJ)
AF:
0.438
AC:
4078
AN:
9302
East Asian (EAS)
AF:
0.243
AC:
3223
AN:
13242
South Asian (SAS)
AF:
0.525
AC:
8939
AN:
17012
European-Finnish (FIN)
AF:
0.472
AC:
153
AN:
324
Middle Eastern (MID)
AF:
0.464
AC:
941
AN:
2028
European-Non Finnish (NFE)
AF:
0.511
AC:
409406
AN:
800976
Other (OTH)
AF:
0.462
AC:
15114
AN:
32682
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
10694
21387
32081
42774
53468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15396
30792
46188
61584
76980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.392
AC:
59598
AN:
152028
Hom.:
13186
Cov.:
32
AF XY:
0.391
AC XY:
29019
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.181
AC:
7506
AN:
41484
American (AMR)
AF:
0.408
AC:
6235
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.456
AC:
1581
AN:
3468
East Asian (EAS)
AF:
0.261
AC:
1354
AN:
5180
South Asian (SAS)
AF:
0.518
AC:
2488
AN:
4806
European-Finnish (FIN)
AF:
0.445
AC:
4692
AN:
10550
Middle Eastern (MID)
AF:
0.412
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
0.506
AC:
34370
AN:
67942
Other (OTH)
AF:
0.407
AC:
859
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1719
3437
5156
6874
8593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.464
Hom.:
46913
Bravo
AF:
0.378
Asia WGS
AF:
0.352
AC:
1226
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.4
DANN
Benign
0.70
PhyloP100
-0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10780691; hg19: chr9-87491253; API